HDAC3 inhibition significantly suppressed IL-1β-induced inflammatory gene expression in RA FLS, at the same level of pan-HDAC inhibition, but without possible side effects such as thrombocytopenia (60). Here, HDAC9 is linked to rheumatoid arthritis.